HIND

NASDAQ 已收盘

Vyome Holdings

1.20 USD
▼-0.25-17.24%
盘后 1.21 +0.83%
2026-11-20
市值
$8.42M
市盈率
—
EPS
-0.54
股息率
—
52 周区间
1.20 – 5.88
成交量
34.95K
Beta
—
目标价
8.83
52W 低 1.2052W 高 5.88
价格走势

公司简介

Vyome Holdings, Inc., a clinical-stage specialty pharmaceutical company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States. It operates through Pharmaceutical and Biotechnology segments. The company’s lead product candidate VT-1953, a dual DNA Gyrase/Topoisomerase inhibitor and immunomodulator in a topical gel formulation that is in phase 2 clinical stage for the treatment of bacterial conjunctivitis. It also develops VT-1908, a topical eye drop is an inosine 5′-monophosphate dehydrogenase enzyme...